QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=DF855E1FCDC082CA178D4759DE591992;jsessionid=CEC07D6E3BD976C0A49BA3484965CE27;jsessionid=CC2B2FF77BE70ED30A59008DC57D82D7;jsessionid=BCDCBA568148BCE772D8C18BD107F409;jsessionid=87BCD66CB73E0442B3535617CE520F90;jsessionid=5BCCFF7DDB55C18A93D617B230EF8FE1;jsessionid=C61C92ECEC096E5F73A6467D8DA274CF;jsessionid=280B9169D55F8D795A28847DE1CB24E3;jsessionid=1B49B750151FE98AA2E3536A158A69BE;jsessionid=81245F688B16A9A77792758883DE27D3 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=DF855E1FCDC082CA178D4759DE591992;jsessionid=CEC07D6E3BD976C0A49BA3484965CE27;jsessionid=CC2B2FF77BE70ED30A59008DC57D82D7;jsessionid=BCDCBA568148BCE772D8C18BD107F409;jsessionid=87BCD66CB73E0442B3535617CE520F90;jsessionid=5BCCFF7DDB55C18A93D617B230EF8FE1;jsessionid=C61C92ECEC096E5F73A6467D8DA274CF;jsessionid=280B9169D55F8D795A28847DE1CB24E3;jsessionid=1B49B750151FE98AA2E3536A158A69BE;jsessionid=81245F688B16A9A77792758883DE27D3